Finance

Lists
PANACEABIO:NSE
Panacea Biotec Ltd
360,00 ₹
+0,84%
(+3,00) 1D
16 қаз., 15:30:02 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PANACEABIO...
Open
356,60 ₹
High
363,45 ₹
Low
351,00 ₹
Mkt. cap
22,05 млрд
Avg. vol.
85,54 мың
Volume
25,78 мың
52-wk high
647,00 ₹
52-wk low
292,40 ₹
EPS
-1,16 ₹
Shares outstanding
61,25 млн
No. of employees
2 мың
Open
356,60 ₹
High
363,45 ₹
Low
351,00 ₹
Mkt. cap
22,05 млрд
Avg. vol.
85,54 мың
Volume
25,78 мың
52-wk high
647,00 ₹
52-wk low
292,40 ₹
EPS
-1,16 ₹
Shares outstanding
61,25 млн
No. of employees
2 мың
News stories
From web sources and news partners
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2,1 мың
Founded1984
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,41 млрд
1,65 млрд
1,67 млрд
2,00 млрд
Cost of goods sold
589,40 млн
679,30 млн
763,93 млн
1,02 млрд
Cost of revenue
589,40 млн
679,30 млн
763,93 млн
1,02 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477,10 млн
405,30 млн
607,88 млн
441,60 млн
Operating expense
1,08 млрд
939,70 млн
849,37 млн
1,00 млрд
Total operating expenses
1,67 млрд
1,62 млрд
1,61 млрд
2,02 млрд
Operating income
-261,30 млн
32,90 млн
54,24 млн
-22,30 млн
Other non operating income
64,00 млн
22,80 млн
-149,85 млн
42,40 млн
EBT including unusual items
-191,70 млн
64,90 млн
-12,49 млн
35,70 млн
EBT excluding unusual items
-218,70 млн
37,20 млн
-47,72 млн
8,30 млн
Income tax expense
-51,60 млн
26,00 млн
-2,46 млн
13,70 млн
Effective tax rate
26,92%
40,06%
19,70%
38,38%
Other operating expenses
522,70 млн
449,90 млн
162,69 млн
480,30 млн
Net income
-139,20 млн
39,80 млн
5,13 млн
23,00 млн
Net profit margin
-9,86%
2,41%
0,31%
1,15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
41,64 млн
-
Interest expense
-21,40 млн
-18,50 млн
-5,60 млн
-11,80 млн
Net interest expenses
-21,40 млн
-18,50 млн
36,04 млн
-11,80 млн
Depreciation and amortization charges
83,40 млн
84,50 млн
78,80 млн
79,00 млн
EBITDA
-177,60 млн
113,44 млн
129,51 млн
60,35 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары